BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14784)

  • 1. Inhibitors of L-asparagine synthetase, in vitro.
    Cooney DA; Driscoll JS; Milman HA; Jayaram HN; Davis RD
    Cancer Treat Rep; 1976 Oct; 60(10):1493-557. PubMed ID: 14784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Asparagine synthetase in serum as a marker for neoplasia.
    Cooney DA; King VD; Cable RG; Taylor B; Wodinsky I
    Cancer Res; 1976 Sep; 36(9 pt.1):3238-45. PubMed ID: 10081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; King WM; Cragoe EJ
    Biochem Pharmacol; 1975 Oct; 24(19):1787-92. PubMed ID: 9943
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminomalonic acid and its congeners as potential in vivo inhibitors of L-asparagine synthetase.
    Milman HA; Muth R; Cooney DA
    Enzyme; 1979; 24(1):36-47. PubMed ID: 35346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of asparagine synthetase inhibitors on asparaginase resistant tumors.
    Uren JR; Chang PK; Handschumacher RE
    Biochem Pharmacol; 1977 Aug; 26(15):1405-10. PubMed ID: 20104
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of L-asparagine synthetase by mineral cations.
    Milman HA; Cooney DA; Ward JM
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):573-80. PubMed ID: 42170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aspartyladenylate analog--effective inhibitor of asparagine synthetase].
    Zhukov IuN; Biriukov AI; Khomutov RM
    Bioorg Khim; 1988 Jul; 14(7):969-72. PubMed ID: 2903747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogs of L-aspartic acid in chemotherapy for cancer.
    Jayaram HN; Cooney DA
    Cancer Treat Rep; 1979 Jun; 63(6):1095-108. PubMed ID: 38003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogs.
    Parr IB; Boehlein SK; Dribben AB; Schuster SM; Richards NG
    J Med Chem; 1996 Jun; 39(12):2367-78. PubMed ID: 8691431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antitumor agents via inhibitors of L-asparagine synthetase: substituted sulfonamides and sulfonyl hydrazides related to glutamine.
    Brynes S; Fiorina VJ; Cooney DA; Milman HA
    J Pharm Sci; 1978 Nov; 67(11):1550-3. PubMed ID: 30838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
    Uren JR
    Cancer Treat Rep; 1981; 65 Suppl 4():47-55. PubMed ID: 6125260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rat liver asparagine synthetase by Cibacron Blue F3GA.
    Hongo S; Sato T
    Enzyme; 1984; 31(3):181-6. PubMed ID: 6145587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
    Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
    Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of L-asparagine synthetase by mucochloric and mucobromic acids.
    Cooney DA; Milman HA; Jayaram HN; Homan ER
    Enzyme; 1976; 21(6):524-39. PubMed ID: 12938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase.
    Li BS; Gu LJ; Luo CY; Li WS; Jiang LM; Shen SH; Jiang H; Shen SH; Zhang B; Chen J; Xue HL; Tang JY
    Leukemia; 2006 Dec; 20(12):2199-201. PubMed ID: 17039232
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential inhibitors of L-asparagine biosynthesis. 3. Aromatic sulfonyl fluoride analogs of L-asparagine and L-glutamine.
    Mokotoff M; Brynes S; Bagaglio JF
    J Med Chem; 1975 Sep; 18(9):888-91. PubMed ID: 240024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic mechanism of Escherichia coli asparagine synthetase B.
    Boehlein SK; Stewart JD; Walworth ES; Thirumoorthy R; Richards NG; Schuster SM
    Biochemistry; 1998 Sep; 37(38):13230-8. PubMed ID: 9748330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic mechanism of asparagine synthetase from Vibrio cholerae.
    Fresquet V; Thoden JB; Holden HM; Raushel FM
    Bioorg Chem; 2004 Apr; 32(2):63-75. PubMed ID: 14990305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
    Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
    Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.